Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Expert Opinion on Drug Discovery|July 1, 2015
Improving attrition rates in Ebola virus drug discoverySanja Glisic, Slobodan Paessler, Nevena Veljkovic, et al.
F1000Research|May 23, 2017
A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy dietVeljko Veljkovic, Vladimir Perovic, Marko Anderluh, et al.
Plos One|November 10, 2016
Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from ChinaVeljko Veljkovic, Nevena Veljkovic, Slobodan Paessler, et al.
Frontiers in Microbiology|January 7, 2016
Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New PandemicVeljko Veljkovic, Slobodan Paessler, Sanja Glisic, et al.
Chemistryopen|February 1, 2022
Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational ApproachMilan Sencanski, Vladimir Perovic, Jelena Milicevic, et al.
Antiviral Therapy|February 29, 2020
In vitro anti-influenza activity of in silico repurposed candidate drug cycrimineStanislava Matejin, Natalya Bukreyeva, Draginja Radosevic, et al.
F1000Research|July 14, 2015
In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus diseaseVeljko Veljkovic, Marco Goeijenbier, Sanja Glisic, et al.
Frontiers in Cellular and Infection Microbiology|April 12, 2019
Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel InhibitorsDraginja Radosevic, Milan Sencanski, Vladimir Perovic, et al.
Plos Pathogens|May 16, 2022
Ehrlichia SLiM ligand mimetic activates Hedgehog signaling to engage a BCL-2 anti-apoptotic cellular programCaitlan D Byerly, Shubhajit Mitra, LaNisha L Patterson, et al.
Pageof 21